Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder

ClinicalTrials.gov ID: NCT06021522

Public ClinicalTrials.gov record NCT06021522. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 8:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-Label, Study to Evaluate the Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to evaluate the long-term safety and tolerability of ecopipam tablets in children (greater than or equal to \[\>=\] 6 and less than \[\<\] 12 years of age), adolescents (\>=12 and \<18 years of age), and adults (\>=18 years of age) with Tourette's Syndrome (TS).

Study identification

NCT ID
NCT06021522
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Emalex Biosciences Inc.
Industry
Enrollment
150 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
6 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 16, 2023 (Actual)
Primary completion
Feb 2028 (Estimated)
Completion
Feb 2028 (Estimated)
Last update posted
Jul 22, 2026

2023 – 2028

United States locations

U.S. sites
44
U.S. states
24
U.S. cities
39
Facility City State ZIP Site status
Harmonex, Inc. Dothan Alabama 36303 —
Arkansas Children's Hospital Little Rock Arkansas 72202 —
Advanced Research Center Anaheim California 92805 —
CenExel CIT-IE Bellflower California 90706 —
Cortica Site Network Glendale California 91203 —
Cortica Site Network - San Rafael San Rafael California 94903 —
Yale School of Medicine New Haven Connecticut 06519 —
Childrens National Hospital Washington D.C. District of Columbia 20010 —
NW FL Clinical Research Group, LLC Gulf Breeze Florida 32561 —
Research in Miami Inc Hialeah Florida 33013-3834 —
University of Miami Miller School of Medicine Miami Florida 33136 —
Florida International Research Center Miami Florida 33173 —
Medical Research Group of Central Florida Orange City Florida 32763 —
APG Research, LLC Orlando Florida 32803 —
University of South Florida St. Petersburg Florida 33701 —
Pediatric Epilepsy and Neurology Specialists Tampa Florida 33609 —
Rare Disease Research, LLC Atlanta Georgia 30329 —
Lurie Children Hospital of Chicago Chicago Illinois 60611 —
Rush University Medical Center Chicago Illinois 60612 —
Josephson-Wallack-Munshower Neurology Indianapolis Indiana 46256 —
University of Louisville Research Foundation Inc. Louisville Kentucky 40202 —
Kennedy Krieger Institute Baltimore Maryland 21205 —
Mass General Hospital Boston Massachusetts 02114 —
Boston Childrens Hospital Boston Massachusetts 02115 —
Umass Chan Medical School Worcester Massachusetts 01655 —
Michigan Clinical research Institute PC Ann Arbor Michigan 48105 —
Neurobahavioral Medicine Group Bloomfield Hills Michigan 48302 —
St. Louis Children's Hospital St Louis Missouri 63110 —
Alivation Research Lincoln Nebraska 68526 —
University of Rochester Rochester New York 14642 —
OnSite Clinical Solutions LLC Charlotte North Carolina 28211 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 —
National Childrens Hospital - The Ohio State University Columbus Ohio 43205 —
North Star Medical Research, LLC Middleburg Heights Ohio 44130 —
Providence Brain and Spine Institute Portland Oregon 97225 —
Coastal Pediatric Research Charleston South Carolina 29414 —
Access Clinical Trials, Inc. Nashville Tennessee 37203-6502 —
Access Clinical Trials, Inc. Nashville Tennessee 37203 —
Vanderbilt University Medical Center Nashville Tennessee 37232-2551 —
UT Southwestern Dallas Texas 75390 —
The University of Texas Health Science Center at Houston Houston Texas 77030 —
Road Runner Research, Ltd San Antonio Texas 78249 —
Cedar Clinical Research Draper Utah 84020 —
Core Clinical Research Everett Washington 98201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06021522, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 22, 2026 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06021522 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →